Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/314800


An Exploration of Consolidation in the Generics Industry


Description: The generics industry worldwide is undergoing an unprecedented period of consolidation. This trend began in the United States during the early and mid 1990s, but the focus turned to Europe and India in the late 1990s and continues into the early part of the 21st century. After the initial flurry of activity in the United States in the early 1990s, U.S. generics companies have shown little recent activity in terms of acquisitions, but elsewhere both the pace and scale of this consolidation have accelerated since 2000.

In this report, we examine the wave of M&As taking place across the generics sector and explore the reasons behind this consolidation, such as the competitive pressures in operation, the need for greater mass, and the use of acquisitions to facilitate market entry. We consider the implications of consolidation for the U.S. generics industry and other developed markets as the generics industry becomes more international in character and discuss the future of the generics industry and its likely impact on the branded pharmaceutical industry.



Contents: Overview

The Generics Market at a Glance

Factors Driving Industry Consolidation
Cost Pressures
Need for Greater Size and Economies of Scale
Entry into New Geographic Markets
Gaining Access to New
Therapeutic Areas and New Technologies

Generics Industry M&A Activity in Review
Generics Industry Leaders
Follow an Aggressive Acquisition Strategy
U.S. Companies Remain
Focused on the Domestic Market
Indian Companies of All
Sizes Seek Entry into Overseas Markets

Outlook

List of Tables and Figures

Figure 1. U.S. Patent Expiries for the Top 40 Best Selling Drugs, 2005-2021
Figure 2. Impact of Consolidation on Market Share in the German Generics Market, 1999-2004
Table 1. Select Generics Company Acquisitions, 2000-2005
Table 2. Leading Generics Companies by Sales, 2004
Table 3. Select Teva Acquisitions, 1980-2005
Table 4. Select Sandoz/Novartis Acquisitions, 1963-2005
Table 5. Select Merck KGaA Acquisitions, 1994-2005




Companies Mentioned Companies mentioned in this report include: - Abic - Able Laboratories - Actavis - Alpharm France - Amarin Development - Amide Pharmaceutical - Amifarma - Apotek - APS/Berk - Barr Laboratories - BASF Generics - Bayer Basics - Bayer Classics - Bayer Self-Medication - Biogal - Biotechna - Copley Pharmaceutical - CP Pharmaceuticals - Dorom - Duramed Pharmaceuticals - Durascan - Endeavour Pharmaceuticals - Eon Labs - Esparma - Galena - GlaxoSmithKline - Glenmark Pharmaceuticals - GRY-Pharma - Heumann Pharma - Hexal - Hikal - Human Serum & Pharmceutical Manufacturing - Ikapharm - Ivax - Johnson & Johnson - Kali Laboratories - Katwijk Farma - Laboratorios Klinger - Lagap - Lek PharmaTech - Lemmon - Makoff R&D Laboratories - Marsing - Merck KGaA - Migada - Netpharm Scandanavia - NM Pharma - Novartis - Novopharm - Par Pharmaceutical - Pfizer - Pharbil - Pharmchemie - Polfa Kutno - Prasfarma - Prosintex - Ranbaxy - Ratiopharm - RPG Aventis - Sabex - Sandoz - Sandoz-Hexal-Azupharma - Schein Pharmaceutical - Sicor - Stada - Teva - Torrent Pharmaceuticals - Tutag - Watson Pharmaceuticals - Wockhardt - Zydus Cadila


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/314800

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 05/09/2008 21:55:33
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
An Exploration of Consolidation in the Generics Industry

Web Address:
http://www.researchandmarkets.com/reports/314800

Office Code:
OCHHGMNKPWY

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €695.00




Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 05/09/2008 21:55:33


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World